UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Obstetrics and gynecology (New York. 1953), ISSN 0029-7844, 01/2009, Volume 113, Issue 1, pp. 18 - 25
Life Sciences & Biomedicine | Obstetrics & Gynecology | Science & Technology | Gynecology. Andrology. Obstetrics | Biological and medical sciences | Medical sciences | Female genital diseases | Tumors | Cervical Intraepithelial Neoplasia - pathology | Colposcopy | Uterine Cervical Neoplasms - diagnosis | Humans | Cervical Intraepithelial Neoplasia - diagnosis | Uterine Cervical Neoplasms - pathology | Papillomaviridae - isolation & purification | Cervical Intraepithelial Neoplasia - virology | Cervical Intraepithelial Neoplasia - therapy | Uterine Cervical Neoplasms - virology | Female | Neoplasm Regression, Spontaneous | Uterine Cervical Neoplasms - therapy | Index Medicus | Abridged Index Medicus
Journal Article
The Journal of infectious diseases, ISSN 0022-1899, 6/2007, Volume 195, Issue 11, pp. 1582 - 1589
Human papillomavirus 16 | Colposcopy | Humans | Predisposing factors | Squamous cell neoplasms | Viruses | Infections | Triage | Prospective studies | Lesions | Cervical cancer | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Biological and medical sciences | Medical sciences | Virology | Neoplasms, Squamous Cell - diagnosis | Markov Chains | Prevalence | Prospective Studies | Human papillomavirus 16 - classification | Middle Aged | DNA, Viral - analysis | Neoplasms, Squamous Cell - virology | Papillomaviridae - genetics | Incidence | Human papillomavirus 16 - isolation & purification | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Adult | Female | Papillomavirus Infections - virology | Papillomavirus Infections - complications | Uterine Cervical Neoplasms - diagnosis | Papillomavirus Infections - epidemiology | Risk Factors | Cervical Intraepithelial Neoplasia - diagnosis | Vaginal Smears | Papillomaviridae - isolation & purification | Cervical Intraepithelial Neoplasia - virology | Papillomaviridae - classification | Uterine Cervical Neoplasms - virology | Human papillomavirus 16 - genetics | Women | Development and progression | Research | Papillomavirus infections | Health aspects | Index Medicus | Abridged Index Medicus | Life Sciences | Other
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9574, pp. 1693 - 1702
Internal Medicine | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Prevention and actions | Papillomaviridae - immunology | Multicenter Studies as Topic | Papillomavirus Infections - prevention & control | Humans | Adolescent | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Papillomavirus Vaccines | Randomized Controlled Trials as Topic | Prevention | Complications and side effects | Vulvar cancer | Papillomavirus infections | Vaginal cancer | Studies | Health facilities | Human papillomavirus | Data analysis | Immunization | Disease | Womens health | Mortality | Clinical trials | Cervical cancer | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 1, pp. 20 - 21
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 100 - 110
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Precancerous Conditions - diagnosis | Precancerous Conditions - virology | Time Factors | Adult | Female | Papillomavirus Infections - virology | Precancerous Conditions - pathology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Cross Reactions | Antigens, Viral - immunology | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Precancerous Conditions - prevention & control | Australia | Human papillomavirus 16 - genetics | Prevention | Medical colleges | Analysis | Oncology, Experimental | Clinical trials | Cross infection | Vaccines | Nosocomial infections | Research | Papillomavirus infections | Cancer | Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2015, Volume 16, Issue 7, pp. 775 - 786
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Human papillomavirus 18 - immunology | Adjuvants, Immunologic - administration & dosage | Age Factors | Follow-Up Studies | United States | Humans | Human papillomavirus 16 - immunology | Costa Rica | Dose-Response Relationship, Drug | Young Adult | Human papillomavirus 16 - isolation & purification | Vaccination - methods | Time Factors | Adult | Female | Papillomavirus Vaccines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Treatment Outcome | Cervical Intraepithelial Neoplasia - virology | Human papillomavirus 18 - isolation & purification | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2007, Volume 369, Issue 9580, pp. 2161 - 2170
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | DNA, Viral - drug effects | Papillomavirus Infections - complications | Human papillomavirus 16 - pathogenicity | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Humans | DNA, Viral - isolation & purification | Human papillomavirus 16 - drug effects | Papillomavirus Vaccines - pharmacology | Cervical Intraepithelial Neoplasia - virology | Cervical Intraepithelial Neoplasia - etiology | Human papillomavirus 18 - drug effects | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Adult | Female | Prevention | Research | Demographic aspects | Papillomavirus infections | Papillomaviruses | Analysis | Young women | Clinical trials | Vaccines | Health aspects | Immunization | Young adults | Histology | Infections | Gene expression | Cells | Hepatitis | Human papillomavirus | Womens health | Biopsy | Informed consent | Autoimmune diseases | Cervical cancer | Deoxyribonucleic acid--DNA | Index Medicus | Abridged Index Medicus
Journal Article
The lancet oncology, ISSN 1470-2045, 2012, Volume 13, Issue 1, pp. 89 - 99
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | South America | Cervical Intraepithelial Neoplasia - pathology | Human papillomavirus 18 - immunology | Adenocarcinoma - pathology | Adjuvants, Immunologic - administration & dosage | Age Factors | Humans | Lipid A - analogs & derivatives | DNA, Viral - analysis | Uterine Cervical Neoplasms - pathology | Aluminum Hydroxide - administration & dosage | Human papillomavirus 16 - immunology | North America | Papillomavirus Infections - diagnosis | Young Adult | Neoplasm Grading | Time Factors | Adult | Female | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | Papillomavirus Vaccines - administration & dosage | Lipid A - administration & dosage | Uterine Cervical Neoplasms - diagnosis | Double-Blind Method | Europe | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - diagnosis | Treatment Outcome | Adenocarcinoma - virology | Cervical Intraepithelial Neoplasia - virology | Adenocarcinoma - diagnosis | Adenocarcinoma - prevention & control | Asia | Papillomavirus Infections - prevention & control | Adolescent | Cervical Intraepithelial Neoplasia - prevention & control | Uterine Cervical Neoplasms - virology | Australia | Human papillomavirus 16 - genetics | Medical colleges | Care and treatment | Cervix dysplasia | Vaccination | Oncology, Experimental | Clinical trials | Vaccines | Research | Prevention | Sexually transmitted diseases | Analysis | Cross infection | Adults | Nosocomial infections | Children | Papillomavirus infections | Health aspects | Cervical cancer | Public health | Cancer | Index Medicus
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2007, Volume 356, Issue 19, pp. 1928 - 1943
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Public health. Hygiene-occupational medicine | Public health. Hygiene | Biological and medical sciences | General aspects | Medical sciences | Prevention and actions | Double-Blind Method | Follow-Up Studies | Humans | Condylomata Acuminata - epidemiology | Genital Neoplasms, Female - prevention & control | Carcinoma in Situ - prevention & control | Genital Neoplasms, Female - epidemiology | Condylomata Acuminata - prevention & control | Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | Alphapapillomavirus - isolation & purification | DNA, Viral - blood | Adenocarcinoma - prevention & control | Alphapapillomavirus - genetics | Papillomavirus Infections - prevention & control | Carcinoma in Situ - epidemiology | Adolescent | Papillomavirus Vaccines - adverse effects | Adult | Female | Prevention | Genital diseases, Female | Disease prevention | Clinical trials | Human papillomavirus | Vaccines | Clinical outcomes | Cervical cancer | Index Medicus | Abridged Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2004, Volume 364, Issue 9447, pp. 1757 - 1765
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Dose-Response Relationship, Immunologic | Humans | Neutralization Tests | Viral Vaccines - adverse effects | Antibodies, Viral - blood | Papillomaviridae - immunology | Uterine Cervical Diseases - immunology | Adult | Female | Immunization Schedule | Papillomavirus Vaccines | Uterine Cervical Diseases - prevention & control | Cervix Uteri - virology | Double-Blind Method | Enzyme-Linked Immunosorbent Assay | Uterine Cervical Neoplasms - prevention & control | Cervical Intraepithelial Neoplasia - virology | Viral Vaccines - administration & dosage | Capsid - immunology | Uterine Cervical Diseases - virology | Papillomavirus Infections - prevention & control | Capsid Proteins | Adolescent | Uterine Cervical Neoplasms - virology | Oncogene Proteins, Viral - immunology | Viral Vaccines - immunology | Prevention | Viral vaccines | Complications | Product development | Papillomavirus infections | Cervical cancer | Risk factors | Complications and side effects | Women | Viruses | Infections | Vaccines | Index Medicus | Abridged Index Medicus
Journal Article